Connect with us

Technology

MongoDB, Inc. Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results

Published

2 years ago

on

Fourth Quarter Fiscal 2025 Total Revenue of $548.4 million, up 20% Year-over-Year

Full Year Fiscal 2025 Total Revenue of $2.01 billion, up 19% Year-over-Year

Continued Strong Customer Growth with Over 54,500 Customers as of January 31, 2025

MongoDB Atlas Revenue up 24% Year-over-Year; 71% of Total Q4 Revenue

NEW YORK, March 5, 2025 /PRNewswire/ — MongoDB, Inc. (NASDAQ: MDB) today announced its financial results for the fourth quarter and fiscal year ended January 31, 2025.

“MongoDB delivered a strong end to fiscal 2025 with 24% Atlas revenue growth and significant margin expansion. Atlas consumption in the quarter was better than expected and we continue to see good performance in new workload wins due to the flexibility, scalability and performance of the MongoDB platform. In fiscal year 2026 we expect to see stable consumption growth in Atlas, our main growth driver,” said Dev Ittycheria, President and Chief Executive Officer of MongoDB.

“Looking ahead, we remain incredibly excited about our long-term growth opportunity. MongoDB removes the constraints of legacy databases, enabling businesses to innovate at AI speed with our flexible document model and seamless scalability. Following the Voyage AI acquisition, we combine real-time data, sophisticated embedding and retrieval models and semantic search directly in the database, simplifying the development of trustworthy AI-powered apps.”

Fourth Quarter Fiscal 2025 Financial Highlights

Revenue: Total revenue was $548.4 million for the fourth quarter of fiscal 2025, an increase of 20% year-over-year. Subscription revenue was $531.0 million, an increase of 19% year-over-year, and services revenue was $17.4 million, an increase of 34% year-over-year.Gross Profit: Gross profit was $399.4 million for the fourth quarter of fiscal 2025, representing a 73% gross margin compared to 75% in the year-ago period. Non-GAAP gross profit was $411.7 million, representing a 75% non-GAAP gross margin, compared to a non-GAAP gross margin of 77% in the year-ago period.Loss from Operations: Loss from operations was $18.6 million for the fourth quarter of fiscal 2025, compared to a loss from operations of $71.0 million in the year-ago period. Non-GAAP income from operations was $112.5 million, compared to non-GAAP income from operations of $69.2 million in the year-ago period.Net Income (Loss): Net income was $15.8 million, or $0.20 per share, based on 77.6 million weighted-average shares outstanding, for the fourth quarter of fiscal 2025. This compares to a net loss of $55.5 million, or $0.77 per share, in the year-ago period. Non-GAAP net income was $108.4 million, or $1.28 per share, based on 84.6 million fully diluted weighted-average shares outstanding. This compares to a non-GAAP net income of $71.1 million, or $0.86 per share, in the year-ago period.Cash Flow: As of January 31, 2025, MongoDB had $2.3 billion in cash, cash equivalents, short-term investments and restricted cash. During the three months ended January 31, 2025, MongoDB generated $50.5 million of cash from operations, compared to $54.6 million of cash from operations in the year-ago period. MongoDB used $26.0 million of cash in capital expenditures and used $1.6 million of cash in principal payments of finance leases, leading to free cash flow of $22.9 million, compared to free cash flow of $50.5 million in the year-ago period.

Full Year Fiscal 2025 Financial Highlights

Revenue: Total revenue was $2.01 billion for the full year fiscal 2025, an increase of 19% year-over-year. Subscription revenue was $1.94 billion, an increase of 19% year-over-year, and services revenue was $62.6 million, an increase of 12% year-over-year.Gross Profit: Gross profit was $1.47 billion for the full year fiscal 2025, representing a 73% gross margin compared to 75% in the year-ago period. Non-GAAP gross profit was $1.52 billion, representing a 76% non-GAAP gross margin, compared to a non-GAAP gross margin of 77% in the year-ago period.Loss from Operations: Loss from operations was $216.1 million for the full year fiscal 2025, compared to a loss from operations of $233.7 million in the year-ago period. Non-GAAP income from operations was $299.3 million, compared to a non-GAAP income from operations of $270.4 million in the year-ago period.Net Loss: Net loss was $129.1 million, or $1.73 per share, based on 74.6 million weighted-average shares outstanding, for the full year fiscal 2025. This compares to a net loss of $176.6 million, or $2.48 per share in the year-ago period. Non-GAAP net income was $308.2 million, or $3.66 per share based on 84.1 million fully diluted weighted-average shares outstanding. This compares to a non-GAAP net income of $274.2 million, or $3.33 per share, in the year-ago period.Cash Flow: During the year ended January 31, 2025, MongoDB generated $150.2 million of cash from operations, compared to $121.5 million of cash from operations in the year-ago period. MongoDB used $29.6 million of cash in capital expenditures and used $6.2 million of cash in principal payments of finance leases, leading to free cash flow of $114.5 million, compared to free cash flow of $109.9 million in the year-ago period.

A reconciliation of each non-GAAP measure to the most directly comparable GAAP measure has been provided in the financial statement tables included at the end of this press release. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures.”

Fourth Quarter Fiscal 2025 and Recent Business Highlights

MongoDB acquired Voyage AI, a pioneer in state-of-the-art embedding and reranking models that power next-generation AI applications. Integrating Voyage AI’s technology with MongoDB will enable organizations to easily build trustworthy, AI-powered applications by offering highly accurate and relevant information retrieval deeply integrated with operational data.MongoDB completed the redemption of 2026 Convertible Notes, eliminating all debt from the balance sheet. Additionally, in conjunction with the acquisition of Voyage, MongoDB is announcing a stock buyback program of $200 million, to offset the dilutive impact of the acquisition consideration.For the third consecutive year, MongoDB was named a Leader in the 2024 Gartner® Magic Quadrant™ for Cloud Database Management Systems. Gartner evaluated 20 vendors based on Ability to Execute and Completeness of Vision.Lombard Odier, a Swiss private bank, partnered with MongoDB to migrate and modernize its legacy banking technology systems on MongoDB with generative AI. The initiative enabled the bank to migrate code 50-60 times quicker and move applications from a legacy relational database to MongoDB 20 times faster than previous migrations.

First Quarter and Full Year Fiscal 2026 Guidance

Based on information available to management as of today, March 5, 2025, MongoDB is issuing the following financial guidance for the first quarter and full year fiscal 2026. Our full year guidance assumes that non-Atlas revenue will decline high-single digits in percentage terms on a year-over-year basis.

First Quarter Fiscal 2026

Full Year Fiscal 2026

Revenue

$524.0 million to $529.0
million

$2.240 billion to $2.280
billion

Non-GAAP Income from
Operations

$54.0 million to $58.0
million

$210.0 million to $230.0
million

Non-GAAP Net Income per
Share

$0.63 to $0.67

$2.44 to $2.62

Reconciliations of non-GAAP income from operations and non-GAAP net income per share guidance to the most directly comparable GAAP measures are not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity and low visibility with respect to the charges excluded from these non-GAAP measures; in particular, the measures and effects of stock-based compensation expense specific to equity compensation awards that are directly impacted by unpredictable fluctuations in MongoDB’s stock price. MongoDB expects the variability of the above charges to have a significant, and potentially unpredictable, impact on its future GAAP financial results.

Conference Call Information

MongoDB will host a conference call today, March 5, 2025, at 5:00 p.m. (Eastern Time) to discuss its financial results and business outlook. A live webcast of the call will be available on the “Investor Relations” page of MongoDB’s website at https://investors.mongodb.com. To access the call by phone, please go to this link (registration link), and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at http://investors.mongodb.com.

Forward-Looking Statements

This press release includes certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements concerning MongoDB’s financial guidance for the first fiscal quarter and full year fiscal 2026 and underlying assumptions, our expectations regarding Atlas consumption growth and the benefits of the Voyage AI acquisition. These forward-looking statements include, but are not limited to, plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts and statements identified by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” “would” or the negative or plural of these words or similar expressions or variations. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control including, without limitation: our customers renewing their subscriptions with us and expanding their usage of software and related services; global political changes; the effects of the ongoing military conflicts between Russia and Ukraine and Israel and Hamas on our business and future operating results; economic downturns and/or the effects of rising interest rates, inflation and volatility in the global economy and financial markets on our business and future operating results; our potential failure to meet publicly announced guidance or other expectations about our business and future operating results; our limited operating history; our history of losses; failure of our platform to satisfy customer demands; the effects of increased competition; our investments in new products and our ability to introduce new features, services or enhancements; social, ethical and security issues relating to the use of new and evolving technologies, such as artificial intelligence, in our offerings or partnerships; our ability to effectively expand our sales and marketing organization; our ability to continue to build and maintain credibility with the developer community; our ability to add new customers or increase sales to our existing customers; our ability to maintain, protect, enforce and enhance our intellectual property; the effects of social, ethical and regulatory issues relating to the use of new and evolving technologies, such as artificial intelligence, in our offerings or partnerships; the growth and expansion of the market for database products and our ability to penetrate that market; our ability to integrate acquired businesses and technologies successfully or achieve the expected benefits of such acquisitions, including the acquisition of Voyage AI; the risk of any unexpected costs or expenses resulting from the acquisition of Voyage AI; the risk of any litigation relating to such acquisition; the risk that such acquisition and the announcement of it could have an adverse effect on our operating results and business generally; our ability to maintain the security of our software and adequately address privacy concerns; our ability to manage our growth effectively and successfully recruit and retain additional highly-qualified personnel; and the price volatility of our common stock. These and other risks and uncertainties are more fully described in our filings with the Securities and Exchange Commission (“SEC”), including under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended October 31, 2024, filed with the SEC on December 10, 2024. Additional information will be made available in our Annual Report on Form 10-K for the year ended January 31, 2025, and other filings and reports that we may file from time to time with the SEC. Except as required by law, we undertake no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, changes in expectations or otherwise.

Non-GAAP Financial Measures

This press release includes the following financial measures defined as non-GAAP financial measures by the SEC: non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP income from operations, non-GAAP operating margin, non-GAAP net income, non-GAAP net income per share and free cash flow. Non-GAAP gross profit and non-GAAP gross margin exclude expenses associated with stock-based compensation. Non-GAAP operating expenses, non-GAAP income from operations, non-GAAP operating margin, non-GAAP net income and non-GAAP net income per share exclude:

expenses associated with stock-based compensation including employer payroll taxes upon the vesting and exercising of stock-based awards and expenses related to stock appreciation rights previously issued to our employees in China;amortization of intangible assets for the acquired technology and acquired customer relationships associated with prior acquisitions; andin the case of non-GAAP net income and non-GAAP net income per share, amortization of the debt issuance costs associated with our convertible senior notes and gains or losses on our financial instruments;additionally, non-GAAP net income and non-GAAP net income per share are adjusted for an assumed provision for income taxes based on an estimated long-term non-GAAP tax rate. The non-GAAP tax rate was calculated utilizing a three-year financial projection that excludes the direct impact of the GAAP to non-GAAP adjustments and considers other factors such as operating structure and existing tax positions in various jurisdictions. We intend to periodically reevaluate the projected long-term tax rate, as necessary, for significant events and our ongoing analysis of relevant tax law changes.

MongoDB uses these non-GAAP financial measures internally in analyzing its financial results and believes they are useful to investors, as a supplement to GAAP measures, in evaluating MongoDB’s ongoing operational performance. MongoDB believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing its financial results with other companies in MongoDB’s industry, many of which may present similar non-GAAP financial measures to investors.

Free cash flow represents net cash from/used in operating activities, less capital expenditures, principal payments of finance lease liabilities and capitalized software development costs, if any. MongoDB uses free cash flow to understand and evaluate its liquidity and to generate future operating plans. The exclusion of capital expenditures, principal payments of finance lease liabilities and amounts capitalized for software development facilitates comparisons of MongoDB’s liquidity on a period-to-period basis and excludes items that it does not consider to be indicative of its liquidity. MongoDB believes that free cash flow is a measure of liquidity that provides useful information to investors in understanding and evaluating the strength of its liquidity and future ability to generate cash that can be used for strategic opportunities or investing in its business in the same manner as MongoDB’s management and board of directors.

Non-GAAP financial measures have limitations as an analytical tool and should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. In particular, other companies may report non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP income from operations, non-GAAP net income, non-GAAP net income per share, free cash flow or similarly titled measures but calculate them differently, which reduces their usefulness as comparative measures. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, as presented below. This earnings press release and any future releases containing such non-GAAP reconciliations can also be found on the Investor Relations page of MongoDB’s website at https://investors.mongodb.com.

About MongoDB

Headquartered in New York, MongoDB’s mission is to empower innovators to create, transform, and disrupt industries with software and data. MongoDB’s unified, intelligent data platform was built to power the next generation of applications, and MongoDB is the most widely available, globally distributed database on the market. With integrated capabilities for operational data, search, real-time analytics, and AI-powered retrieval, MongoDB helps organizations everywhere move faster, innovate more efficiently, and simplify complex architectures. Millions of developers and more than 50,000 customers across almost every industry—including 70% of the Fortune 100—rely on MongoDB for their most important applications. To learn more, visit mongodb.com.

Investor Relations
Brian Denyeau
ICR for MongoDB
646-277-1251
ir@mongodb.com 

Media Relations
MongoDB
press@mongodb.com 

 

MONGODB, INC. 
CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share data)
(unaudited)

January 31,
2025

January 31,
2024

Assets

Current assets:

Cash and cash equivalents  

$          490,133

$           802,959

Short-term investments

1,846,444

1,212,448

Accounts receivable, net of allowance for doubtful accounts of $8,888 and $8,054 as of
January 31, 2025 and 2024, respectively 

393,099

325,610

Deferred commissions  

112,632

92,512

Prepaid expenses and other current assets  

81,214

50,107

Total current assets  

2,923,522

2,483,636

Property and equipment, net  

46,377

53,042

Operating lease right-of-use assets

34,607

37,365

Goodwill  

69,679

69,679

Intangible assets, net

24,597

3,957

Deferred tax assets  

20,810

4,116

Other assets  

310,701

217,847

Total assets  

$       3,430,293

$        2,869,642

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable  

$            10,467

$               9,905

Accrued compensation and benefits  

120,354

112,579

Operating lease liabilities

9,126

9,797

Other accrued liabilities  

87,659

74,831

Deferred revenue  

334,381

357,108

Total current liabilities  

561,987

564,220

Deferred tax liability

262

285

Operating lease liabilities

27,374

30,918

Deferred revenue

25,404

20,296

Convertible senior notes, net

—

1,143,273

Other liabilities

33,042

41,661

Total liabilities  

648,069

1,800,653

Stockholders’ equity:

Common stock, par value of $0.001 per share; 1,000,000,000 shares authorized as of
  January 31, 2025 and 2024; 80,558,847 shares issued and 80,467,811 shares outstanding
  as of January 31, 2025 and 72,840,692 shares issued and 72,741,321 shares outstanding as of January 31, 2024

78

73

Additional paid-in capital  

4,625,093

2,777,322

Treasury stock, 99,371 shares (repurchased at an average of $13.27 per share) as of
  January 31, 2025 and 2024

(1,319)

(1,319)

Accumulated other comprehensive income (loss)

(924)

4,545

Accumulated deficit  

(1,840,704)

(1,711,632)

Total stockholders’ equity

2,782,224

1,068,989

Total liabilities and stockholders’ equity

$       3,430,293

$        2,869,642

 

MONGODB, INC. 
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except share and per share data)
(unaudited)

Three Months Ended January 31,

Years Ended January 31,

2025

2024

2025

2024

Revenue:

Subscription  

$       530,958

$       444,939

$     1,943,864

$     1,627,326

Services  

17,440

13,063

62,579

55,685

Total revenue  

548,398

458,002

2,006,443

1,683,011

Cost of revenue:

Subscription(1)

122,676

94,284

441,404

345,233

Services(1)

26,339

20,357

93,892

79,252

Total cost of revenue  

149,015

114,641

535,296

424,485

Gross profit  

399,383

343,361

1,471,147

1,258,526

Operating expenses:

Sales and marketing(1)  

212,211

211,116

871,148

782,760

Research and development(1)  

150,400

145,553

596,837

515,940

General and administrative(1)  

55,334

57,658

219,226

193,558

Total operating expenses  

417,945

414,327

1,687,211

1,492,258

Loss from operations  

(18,562)

(70,966)

(216,064)

(233,732)

Other income, net  

22,716

18,880

84,465

70,216

Loss before provision for (benefit from) income taxes  

4,154

(52,086)

(131,599)

(163,516)

Provision for (benefit from) income taxes  

(11,672)

3,374

(2,527)

13,084

Net income (loss)  

$         15,826

$       (55,460)

$      (129,072)

$      (176,600)

Net income (loss) per share:

Basic

$            0.20

$           (0.77)

$           (1.73)

$           (2.48)

Diluted

$            0.19

$           (0.77)

$           (1.73)

$           (2.48)

Weighted-average shares used to compute net income (loss) per share:

Basic

77,631,824

72,349,350

74,555,001

71,248,982

Diluted

84,594,079

72,349,350

74,555,001

71,248,982

(1) Includes stock‑based compensation expense as follows:

Three Months Ended January 31,

Years Ended January 31,

2025

2024

2025

2024

Cost of revenue—subscription  

$                7,982

$                6,070

$               29,548

$               23,677

Cost of revenue—services  

3,766

3,243

13,917

12,733

Sales and marketing  

40,124

41,340

161,317

159,907

Research and development  

58,156

55,689

226,367

198,927

General and administrative  

15,014

17,469

62,791

61,663

Total stock‑based compensation expense  

$             125,042

$             123,811

$             493,940

$             456,907

 

MONGODB, INC. 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands of U.S. dollars)
(unaudited)

Three Months Ended January 31,

Years Ended January 31,

2025

2024

2025

2024

Cash flows from operating activities

Net income (loss)   

$           15,826

$         (55,460)

$       (129,072)

$       (176,600)

Adjustments to reconcile net income (loss) to net cash provided by 
operating activities:

Depreciation and amortization  

2,171

5,682

11,751

18,939

Stock-based compensation  

125,042

123,811

493,940

456,907

Amortization of debt discount and issuance costs

—

850

2,419

3,393

Amortization of finance right-of-use assets

993

994

3,974

3,975

Amortization of operating right-of-use assets

2,948

2,430

11,248

9,211

Deferred income taxes  

(15,995)

(1,002)

(16,794)

(1,574)

Amortization of premium and accretion of discount on short-
term investments, net

(5,942)

(8,151)

(25,059)

(44,556)

Realized and unrealized loss (gain) on financial
instruments, net

253

250

(937)

(1,044)

Unrealized foreign exchange loss (gain)

(2,956)

2,124

(964)

1,802

Change in operating assets and liabilities:

Accounts receivable, net

(57,978)

(53,400)

(69,236)

(41,639)

Prepaid expenses and other current assets  

(24,231)

(12,908)

(24,813)

(12,208)

Deferred commissions  

(30,333)

(24,670)

(69,127)

(41,830)

Other long-term assets  

(12,973)

4

(30,677)

(211)

Accounts payable  

(1,028)

601

541

1,679

Accrued liabilities  

2,760

19,188

25,254

39,502

Operating lease liabilities

(2,931)

(2,889)

(12,076)

(9,878)

Deferred revenue  

54,990

56,313

(16,362)

(82,411)

Other liabilities, non-current

(78)

860

(3,819)

(1,980)

Net cash provided by operating activities

50,538

54,627

150,191

121,477

Cash flows from investing activities

Purchases of property, equipment and other assets

(25,979)

(2,738)

(29,550)

(6,074)

Investments in non-marketable securities

(5,500)

—

(11,250)

(2,056)

Business combinations, net of cash acquired

—

—

—

(15,000)

Proceeds from the sales of marketable securities

44,984

—

44,984

—

Proceeds from maturities of marketable securities  

182,600

255,000

752,600

1,445,000

Purchases of marketable securities  

(442,421)

—

(1,414,224)

(1,233,851)

Net cash provided by (used in) investing activities

(246,316)

252,262

(657,440)

188,019

Cash flows from financing activities

Proceeds from settlement of capped calls and other

(366)

—

170,223

—

Proceeds from exercise of stock options, including early
  exercised stock options

(16,672)

1,998

1,968

6,810

Proceeds from the issuance of common stock under the
  Employee Stock Purchase Plan

34,427

17,133

36,048

36,914

Principal payments of finance leases

(1,645)

(1,400)

(6,179)

(5,483)

Net cash provided by financing activities

15,744

17,731

202,060

38,241

Effect of exchange rate changes on cash, cash equivalents
and restricted cash  

(2,876)

665

(5,701)

(433)

Net increase (decrease) in cash, cash equivalents and
restricted cash

(182,910)

325,285

(310,890)

347,304

Cash, cash equivalents and restricted cash, beginning of
period  

675,663

478,358

803,643

456,339

Cash, cash equivalents and restricted cash, end of period  

$         492,753

$         803,643

$         492,753

$         803,643

 

MONGODB, INC. 
RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES
(in thousands of U.S. dollars, except share and per share data)
(unaudited)

Three Months Ended January 31,

Years Ended January 31,

2025

2024

2025

2024

Reconciliation of GAAP gross profit to non-GAAP gross
profit:

Gross profit on a GAAP basis

$     399,383

$     343,361

$  1,471,147

$  1,258,526

 Gross margin (Gross profit/Total revenue) on a GAAP basis

73 %

75 %

73 %

75 %

Add back:

 Expenses associated with stock-based compensation: Cost
 of Revenue—Subscription

8,220

6,572

30,365

24,824

 Expenses associated with stock-based compensation: Cost
 of Revenue—Services

4,114

3,694

14,507

14,429

Non-GAAP gross profit

$     411,717

$     353,627

$  1,516,019

$  1,297,779

 Non-GAAP gross margin (Non-GAAP gross profit/Total
 revenue)

75 %

77 %

76 %

77 %

Reconciliation of GAAP operating expenses to non-GAAP
operating expenses:

Sales and marketing operating expense on a GAAP basis

$     212,211

$     211,116

$     871,148

$     782,760

Less:

 Expenses associated with stock-based compensation

41,725

45,713

166,854

176,351

 Amortization of intangible assets

—

85

85

2,365

Non-GAAP sales and marketing operating expense

$     170,486

$     165,318

$     704,209

$     604,044

Research and development operating expense on a GAAP
basis

$     150,400

$     145,553

$     596,837

$     515,940

Less:

 Expenses associated with stock-based compensation

61,091

60,373

234,257

209,052

 Amortization of intangible assets

170

3,085

3,078

8,207

Non-GAAP research and development operating expense

$       89,139

$       82,095

$     359,502

$     298,681

General and administrative operating expense on a GAAP
basis

$       55,334

$       57,658

$     219,226

$     193,558

Less:

 Expenses associated with stock-based compensation

15,725

20,603

66,194

68,932

Non-GAAP general and administrative operating expense

$       39,609

$       37,055

$     153,032

$     124,626

Reconciliation of GAAP loss from operations to non-GAAP
income from operations:

Loss from operations on a GAAP basis

$     (18,562)

$     (70,966)

$   (216,064)

$   (233,732)

 GAAP operating margin (Loss from operations/Total
 revenue)

(3) %

(15) %

(11) %

(14) %

Add back:

 Expenses associated with stock-based compensation

130,874

136,955

512,177

493,588

 Amortization of intangible assets

170

3,170

3,163

10,572

Non-GAAP income from operations

$     112,482

$       69,159

$     299,276

$     270,428

 Non-GAAP operating margin (Non-GAAP Income from
 operations/Total revenue)

21 %

15 %

15 %

16 %

Reconciliation of GAAP net income (loss) to non-GAAP net
income:

Net income (loss) on a GAAP basis

$       15,826

$     (55,460)

$   (129,072)

$   (176,600)

Add back:

 Expenses associated with stock-based compensation

130,874

136,955

512,177

493,588

 Amortization of intangible assets

170

3,170

3,163

10,572

 Amortization of debt issuance costs related to convertible
 senior notes

—

850

2,419

3,393

Less:

 Gains (loss) on financial instruments, net

(253)

—

937

1,294

 Income tax effects and adjustments *

38,762

14,404

79,572

55,465

Non-GAAP net income

$     108,361

$       71,111

$     308,178

$     274,194

Reconciliation of GAAP net income (loss) per share,
diluted, to non-GAAP net income per share, fully diluted:

Net income (loss) per share, diluted, on a GAAP basis

$           0.19

$         (0.77)

$         (1.73)

$         (2.48)

Add back:

 Expenses associated with stock-based compensation

1.55

1.89

6.87

6.93

 Amortization of intangible assets

—

0.04

0.04

0.15

 Amortization of debt issuance costs related to convertible
 senior notes

—

0.01

0.03

0.05

Less:

 Gains (loss) on financial instruments, net

—

—

0.01

0.02

 Income tax effects and adjustments *

0.46

0.20

1.07

0.78

Non-GAAP net income per share, diluted

$           1.28

$           0.97

$           4.13

$           3.85

Adjustment for fully diluted earnings per share

—

(0.11)

(0.47)

(0.52)

Non-GAAP net income per share, fully diluted **

$           1.28

$           0.86

$           3.66

$           3.33

* Non-GAAP financial information is adjusted for an assumed provision for income taxes based on our long-term projected tax rate of 20%. Due to the differences in the tax treatment of items excluded from non-GAAP earnings, our estimated tax rate on non-GAAP income may differ from our GAAP tax rate and from our actual tax liabilities.

** Fully diluted non-GAAP net income per share is calculated based upon 84.6 million and 84.1 million of fully diluted weighted-average shares of outstanding common stock for the three and twelve months ended January 31, 2025, respectively, and 82.9 million and 82.4 million of fully diluted weighted-average shares of outstanding common stock for the three and twelve months ended January 31, 2024, respectively.

 

The following table presents a reconciliation of free cash flow to net cash provided by operating activities, the most 
directly comparable GAAP measure, for each of the periods indicated (unaudited, in thousands):

Three Months Ended January 31,

Years Ended January 31,

2025

2024

2025

2024

Net cash provided by operating activities        

$           50,538

$         54,627

$         150,191

$         121,477

Capital expenditures  

(25,979)

(2,738)

(29,550)

(6,074)

Principal payments of finance leases

(1,645)

(1,400)

(6,179)

(5,483)

Capitalized software 

—

—

—

—

Free cash flow  

$           22,914

$         50,489

$         114,462

$         109,920

 

MONGODB, INC. 
CUSTOMER COUNT METRICS

The following table presents certain customer count information as of the periods indicated:

1/31/2023

4/30/2023

7/31/2023

10/31/2023

1/31/2024

4/30/2024

7/31/2024

10/31/2024

1/31/2025

Total Customers (a)

40,800+

43,100+

45,000+

46,400+

47,800+

49,200+

50,700+

52,600+

54,500+

Direct Sales Customers(b)

6,400+

6,700+

6,800+

6,900+

7,000+

7,100+

7,300+

7,400+

7,500+

MongoDB Atlas Customers

39,300+

41,600+

43,500+

44,900+

46,300+

47,700+

49,200+

51,100+

53,100+

Customers over $100K(c)

1,651

1,761

1,855

1,972

2,052

2,137

2,189

2,314

2,396

(a) Our definition of “customer” excludes users of our free offerings and all affiliated entities are counted as a single customer.

(b) Direct Sales Customers are customers that were sold through our direct sales force and channel partners.

(c) Represents the number of customers with $100,000 or greater in annualized recurring revenue (“ARR”) and annualized monthly recurring revenue (“MRR”). ARR includes the revenue we expect to receive from our customers over the following 12 months based on contractual commitments and, in the case of Direct Sales Customers of MongoDB Atlas, by annualizing the prior 90 days of their actual consumption of MongoDB Atlas, assuming no increases or reductions in their subscriptions or usage. For all other customers of our self-serve products, we calculate annualized MRR by annualizing the prior 30 days of their actual consumption of such products, assuming no increases or reductions in usage. ARR and annualized MRR exclude professional services.

 

MONGODB, INC. 
SUPPLEMENTAL REVENUE INFORMATION

The following table presents certain supplemental revenue information as of the periods indicated:

1/31/2023

4/30/2023

7/31/2023

10/31/2023

1/31/2024

4/30/2024

7/31/2024

10/31/2024

1/31/2025

MongoDB Enterprise
     Advanced: % of
     Subscription
     Revenue

28 %

28 %

26 %

27 %

26 %

25 %

24 %

25 %

23 %

Direct Sales Customers(a)

 Revenue: % of
     Subscription
     Revenue

88 %

88 %

88 %

88 %

88 %

87 %

87 %

88 %

88 %

(a) Direct Sales Customers are customers that were sold through our direct sales force and channel partners.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mongodb-inc-announces-fourth-quarter-and-full-year-fiscal-2025-financial-results-302393702.html

SOURCE MongoDB, Inc.

Related Topics:
Continue Reading

Technology

Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships

Published

54 minutes ago

on

October 23, 2026

By

With 17 new ASC partnerships nationwide to date in 2026, NorthStar Anesthesia emphasizes proactive patient assessment, reliable staffing, and clinical consistency to help surgery centers reduce preventable cancellations and maximize surgical capacity.

IRVING, Texas, Oct. 23, 2026 /PRNewswire/ — As ambulatory surgery centers (ASCs) face mounting financial pressures, staffing challenges, and increasingly complex patient needs, anesthesia has emerged as a critical partner in their ability to operate efficiently and sustainably. NorthStar Anesthesia is addressing these challenges through a dedicated ASC model designed to reduce preventable case cancellations, improve surgical throughput, and help centers make the most of their existing operating room capacity.

NorthStar celebrates 17 new ASC partnerships nationwide to date in 2026.

“The challenge for ASCs today isn’t simply finding anesthesia coverage. It’s ensuring that coverage translates into reliable surgical capacity,” said Cindy Myers, Vice President of ASC Operations at NorthStar Anesthesia. “When cases are cancelled unnecessarily or operating rooms aren’t running as planned, the impact extends well beyond the anesthesia department. Our focus is on helping centers address those challenges systematically, so they can deliver more consistent care and operate more efficiently.”

Reducing Preventable Cancellations Through Better Preparation

One of the most significant opportunities to improve ASC performance lies in the preoperative process. When potential anesthesia concerns are not identified until the day of surgery, patients may face unexpected cancellations, surgeons lose valuable operating time, and centers absorb the cost of unused capacity.

NorthStar addresses this challenge through ASC-specific pre-anesthesia testing (PAT) guidelines and standardized clinical protocols designed to identify potential issues earlier, facilitate appropriate patient optimization, and support consistent decision-making across the surgical process.

“In ambulatory surgery, the decisions made before the patient arrives are often just as important as those made in the operating room,” said Gajan Mahendran, MD, Vice President of Physician Services at NorthStar Anesthesia. “A consistent, evidence-based approach to preoperative assessment helps us identify risks earlier, determine which patients are appropriate for the ASC setting, and address potential barriers to surgery in advance. That means fewer last-minute surprises and a better experience for patients, surgeons, and facilities.”

Aligning Anesthesia Resources With Surgical Demand

Alongside clinical challenges, ASCs are navigating a changing economic environment. In a recent Becker’s ASC Review interview, NorthStar CEO Adam Spiegel noted that approximately 80% of ASCs in NorthStar’s network now require anesthesia stipends, compared with just 10% to 15% before the pandemic.

As anesthesia costs rise, ensuring that staffing levels align with actual surgical demand has become increasingly important. NorthStar works with ASC partners to develop staffing models that reflect each facility’s case mix, surgical volume, and operating requirements. “Adding anesthesia resources doesn’t automatically improve performance if those resources aren’t aligned with the center’s surgical volume,” Myers said. “We work closely with our partners to understand their schedules, case mix, and operational needs so we can build a model that supports both reliable access to care and financial sustainability.”

Combining National Resources With Local Clinical Expertise

As ASCs take on a greater share of surgical procedures, the demands placed on anesthesia providers are becoming more complex. Smaller or locally managed anesthesia groups may face challenges maintaining consistent coverage, recruiting clinicians, or investing in standardized clinical and operational processes.

NorthStar’s model combines local clinical leadership with national recruiting capabilities, dedicated ASC operations expertise, and established quality guidelines. This infrastructure helps support continuity of care, consistent clinical practices, and the flexibility to respond to changes in surgical demand.

The approach is reflected in NorthStar’s expanding ASC partnerships.  To date in 2026 alone, NorthStar has added 17 ASC partnerships, including CarePlex Orthopaedic Ambulatory Surgery Center in Norfolk, Virginia; Stony Point Surgery Center and West Creek Surgery Center, both part of MedRVA Healthcare in Richmond, Virginia; an Orthopedic Surgery Center in Wisconsin; Eye Surgery Center of Homewood in Homewood, Alabama; and The Toledo Clinic ASC in Toledo, Ohio.

These partnerships reflect the growing importance of anesthesia providers that can address both the clinical and operational needs of outpatient surgery centers.

To learn more and to request a confidential anesthesia program assessment, please contact James Bagliani, Director of Business Development, NorthStar Anesthesia at james.bagliani@northstaranesthesia.com. 

About NorthStar Anesthesia

NorthStar Anesthesia is a company of caregivers, founded by an anesthesiologist and a Certified Registered Nurse Anesthetist (CRNA). With more than 4,000 anesthesiologists and CRNAs under its banner, NorthStar partners with more than 280 healthcare client sites across more than 20 states and counting to deliver a more productive and efficient model of anesthesia care. Its care team approach focuses on the provision of high-quality care while measurably improving operating room performance.

Media Contact: James Bagliani, Director of Business Development, NorthStar Anesthesia james.bagliani@northstaranesthesia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/amid-rising-costs-and-surgical-disruptions-in-ascs-northstar-anesthesia-strengthens-focus-on-asc-partnerships-302918226.html

SOURCE NorthStar Anesthesia

Continue Reading

Technology

Dimethylaminopropylamine Market to Reach USD 731.9 Million by 2035 on Surfactant and Epoxy Demand, Credence Research Finds

Published

54 minutes ago

on

October 23, 2026

By

LONDON, Oct. 23, 2026 /PRNewswire/ — Credence Research Inc. has added the “Dimethylaminopropylamine Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035” study to its market intelligence portfolio. The report examines market value, segmentation, demand drivers, regional dynamics, competition and recent industry developments.

The dimethylaminopropylamine (DMAPA) market was valued at USD 452.6 million in 2025 and is projected to reach USD 731.9 million by 2035, representing a 4.92% compound annual growth rate over 2025–2035, according to Credence Research. The firm estimates 2026 revenue at USD 474.3 million. Asia Pacific accounted for the largest modeled geographic share at 44.0% in 2025, while Asia Pacific is projected to grow fastest at 5.88% annually. Market sizes, regional shares and segment shares are Credence Research estimates rather than independently audited industry totals.

Key Takeaways

The market is forecast to increase from USD 452.6 million in 2025 to USD 731.9 million by 2035, with a reported CAGR of 4.92%.Asia Pacific led the modeled 2025 geography with 44.0%; Asia Pacific has the fastest forecast geographic growth of 5.88%.By application, Surfactants accounted for 61.0% of modeled 2025 value, while Epoxy curing agents is forecast to grow at 5.66% a year.By end-use industry, Personal care and cosmetics accounted for 44.0% of modeled 2025 value, while Paints, coatings and composites is forecast to grow at 5.61% a year.The market definition excludes adjacent product or transaction value where that spending is outside the report’s measured scope.

Scope & Segmentation – Dimethylaminopropylamine Market

The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.

By application: Surfactants (betaines and amine oxides); Epoxy curing agents; Polyurethane catalysts; Water treatment chemicals; Agrochemical intermediates; Fuel and lubricant additives; Others.By end-use industry: Personal care and cosmetics; Home care and institutional cleaning; Paints, coatings and composites; Water treatment; Agriculture; Automotive and lubricants.By geography: Asia Pacific; Europe; North America; Latin America; Middle East and Africa.

Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market 

Why This Report Matters

The study distinguishes a narrowly defined revenue pool from adjacent activity that can inflate comparisons between research estimates. This helps strategy teams compare suppliers, customer budgets and product categories on a consistent basis.The base-year segment mix identifies where current purchasing is concentrated, while the modeled faster-growing categories help evaluate investment timing and market entry.Geographic shares are proprietary estimates; company and regulatory announcements are used to explain demand mechanisms, not to independently verify global market totals.

Market Overview
The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.

DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.

The outlook reflects expected changes in customer adoption, procurement, technology and regulation. It should be read as a modeled scenario, not as a guarantee of sales or company performance.

Key Attributes

Attribute

Details

Base year

2025

Historical reference

2018–2025

2025 market size

USD 452.6 million

2026 estimate

USD 474.3 million

2035 market forecast

USD 731.9 million

Reported CAGR

4.92% (2025–2035)

Geographic scope

Global

Primary source

https://www.credenceresearch.com/report/dimethylaminopropylamine-market

Segmentation

By application
The study divides this category into surfactants (betaines and amine oxides); epoxy curing agents; polyurethane catalysts; water treatment chemicals; agrochemical intermediates; fuel and lubricant additives; others. Surfactants led the 2025 value mix with 61.0%. Epoxy curing agents is the fastest-growing modeled subsegment at 5.66% a year. These shares represent Credence Research model outputs, not audited supplier sales.

By end-use industry
The study divides this category into personal care and cosmetics; home care and institutional cleaning; paints, coatings and composites; water treatment; agriculture; automotive and lubricants. Personal care and cosmetics led the 2025 value mix with 44.0%. Paints, coatings and composites is the fastest-growing modeled subsegment at 5.61% a year. These shares represent Credence Research model outputs, not audited supplier sales.

Market Growth Drivers

Mild cleansing formulas sustain high-volume demand
DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.

Epoxy hardeners provide a faster-growth outlet
DMAPA-based amidoamines are used in epoxy curing systems for floors, protective coatings and composite applications. Wind blade production and industrial maintenance provide additional demand. The report models epoxy curing agents as the fastest-growing application, although their value starts below surfactants.

Capacity integration shapes producer economics
The chemical route depends on dimethylamine and acrylonitrile, making feedstock access and energy costs important. Integrated producers can manage these inputs and purity requirements more directly, while regional buyers value dependable supply and local technical support.

Regional Analysis
Asia Pacific held 44.0% of modeled 2025 revenue, while Asia Pacific is expected to record the fastest regional growth at 5.88%. The allocation follows the study’s defined buyer or provider-revenue scope.

Asia Pacific
Asia Pacific represented 44.0% of modeled 2025 market value. China hosts extensive betaine and epoxy manufacturing and new intermediate capacity. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Europe
Europe represented 23.0% of modeled 2025 market value. Specialty formulations and high-purity specifications sustain demand. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

North America
North America represented 21.0% of modeled 2025 market value. Personal care, coating and water treatment buyers support a mature market. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Latin America
Latin America represented 7.0% of modeled 2025 market value. Brazilian and Mexican cleaning and personal care production expands. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Middle East and Africa
Middle East and Africa represented 5.0% of modeled 2025 market value. Industrial chemicals and water treatment provide emerging outlets. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Market Challenges

Input prices and possible overcapacity
Changes in acrylonitrile and dimethylamine costs can pressure margins. New Asian capacity could also exceed near-term demand, creating price competition, especially for producers that lack integrated feedstock or differentiated purity grades.

Handling and product-purity requirements
DMAPA is a hazardous industrial intermediate requiring careful handling. Residual amines in downstream betaines can create sensitization concerns, so cosmetics customers increasingly emphasize analytical control, specifications and supplier qualification.

Future Outlook
Asia Pacific should remain the main production and demand center, with surfactants anchoring volume and epoxy applications contributing above-average growth. Supplier positioning will depend on feedstock integration, reliable logistics, high-purity grades and the pace at which new capacity is absorbed.

Competitive Landscape
BASF and Eastman Chemical are identified as integrated DMAPA producers, while Zhangjiagang Feixiang Chemical and Zhejiang Xinhua Chemical participate in Chinese production. Huntsman is relevant to downstream amine chemistry. Solvay, Evonik and Kao are better described as converters or customers for DMAPA-based surfactants rather than direct merchant DMAPA producers. No credible company-specific DMAPA revenue ranking is available.

Key Players
BASF; Eastman Chemical; Zhangjiagang Feixiang Chemical; Zhejiang Xinhua Chemical; Huntsman (downstream derivatives); Solvay (surfactants); Evonik (surfactants); Kao (surfactants)

Recent Developments

Oct. 16, 2025: BASF said the July start-up of expanded DMAPA production in Nanjing nearly doubled the site’s annual capacity and raised BASF’s global DMAPA capacity by more than 20% to approximately 85,000 metric tons.July 2025: As part of the same Nanjing project, BASF expanded polyetheramine capacity by about 25%. This is a related amine-chain investment, not an additional DMAPA plant.

Report Coverage
The study provides market estimates for 2025 and 2035, a 2026 interim estimate, analysis of the defined product and service scope, segment and geographic revenue shares, demand drivers, technology changes, competitive roles, constraints and recent dated developments. The reported CAGR and regional shares are based on Credence Research’s market model. Company announcements are contextual evidence and should not be interpreted as independent verification of the forecast.

Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market 

Related Reports

https://www.credenceresearch.com/report/apac-infectious-enteritis-treatment-market 

https://www.credenceresearch.com/report/australia-digital-therapeutics-market 

https://www.credenceresearch.com/report/australia-corporate-education-and-upskilling-market 

https://www.credenceresearch.com/report/prescription-drugs-market 

https://www.credenceresearch.com/report/orthopedic-devices-market 

https://www.credenceresearch.com/report/parkinsons-disease-therapeutics-market 

https://www.credenceresearch.com/report/plasma-derived-therapy-market 

https://www.credenceresearch.com/report/over-the-counter-drugs-market 

https://www.credenceresearch.com/report/orphan-drugs-market 

https://www.credenceresearch.com/report/pediatric-drugs-market 

https://www.credenceresearch.com/report/pain-management-drugs-market 

https://www.credenceresearch.com/report/osteoporosis-drugs-market 

https://www.credenceresearch.com/report/patient-monitoring-devices-market 

https://www.credenceresearch.com/report/australia-drive-by-wire-market 

https://www.credenceresearch.com/report/australia-cold-chain-and-refrigerated-transport-market 

https://www.credenceresearch.com/report/australia-critical-illness-insurance-market 

https://www.credenceresearch.com/report/asia-pacific-lysosomal-acid-lipase-deficiency-lal-d-treatment-market 

https://www.credenceresearch.com/report/australia-eco-friendly-labels-market 

https://www.credenceresearch.com/report/apac-healthcare-digital-twins-market 

https://www.credenceresearch.com/report/australia-electric-vehicle-charger-operations-and-maintenance-services-market 

https://www.credenceresearch.com/report/australia-driveline-components-market 

About Us
Credence Research Inc. is a global market intelligence and consulting firm founded in 2015. It provides quantitative market research, competitive intelligence and strategic advisory services to businesses, investors and other organizations. Its research draws on primary and secondary information, industry interviews and structured market models.

The firm analyzes market size, growth drivers, segmentation, regional opportunities, supply chains and competitive positioning across industrial, technology, energy, health care and consumer markets. Its studies help clients evaluate strategic and investment decisions with documented assumptions and industry context.

Contact Us
Credence Research Inc. 
Tower C-1105, S 25, Akash Tower
Vishal Nagar, Pimple Nilakh, Haveli, Pune 411027, India 
USA: +1-888-600-6441 
sales@credenceresearch.com 
www.credenceresearch.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/dimethylaminopropylamine-market-to-reach-usd-731-9-million-by-2035-on-surfactant-and-epoxy-demand-credence-research-finds-302918151.html

Continue Reading

Technology

Misty Ventures and Aplicata Technologies Announce Strategic Partnership to Pursue Canadian Defence Opportunities

Published

54 minutes ago

on

October 23, 2026

By

Together, Aplicata and Misty Ventures will leverage their respective expertise, networks, and resources to support the commercialization of innovative technologies and help bring impactful solutions to government and public-sector markets.

SASKATOON, SK, Oct. 23, 2026 /PRNewswire-PRWeb/ — Misty Ventures, the economic development arm of Mistawasis Nêhiyawak, and Aplicata Technologies, a trusted leader in high-performance computing platforms for mission-critical defence applications, today announced they have signed a Memorandum of Understanding to explore a strategic partnership focused on pursuing and strengthening Canadian defence market opportunities.

“Partnering with Misty Ventures allows us to bring our capabilities to the Canadian defence market in a way that also creates lasting economic benefit for Mistawasis Nêhiyawak. We’re excited about the opportunity to build something meaningful together.” Mohammad Darwish, CEO of Aplicata.

Aplicata and Misty Ventures have agreed to form a Saskatchewan-based joint venture to develop and commercialize electronic warfare (EW), signals intelligence (SIGINT) and intelligence, surveillance and reconnaissance (ISR) technologies for Canadian defence.

The joint venture will deliver solutions across uncrewed aerial vehicles, aircraft, ground vehicles and naval vessels, providing the Canadian Armed Forces with a decisive operational advantage through advanced, mission-critical technology. It brings together Aplicata’s engineering, manufacturing and market expertise with Misty Ventures’ business development experience and its access to skilled talent and defence markets.

A guiding principle of the partnership is to build upon the strong business acumen, entrepreneurial capacity, and strategic vision of Mistawasis Nêhiyawak and its affiliated Indigenous communities. Through this partnership, Mistawasis Nêhiyawak seeks to leverage these strengths to contribute meaningfully to Canada’s defence priorities, supporting the development of sovereign capabilities, domestic innovation, and resilient Canadian supply chains. In addition to technology licensing, Aplicata intends to support the partnership through advanced knowledge and skills development, enabling Mistawasis Nêhiyawak to further expand its participation in Canada’s defence and security ecosystem and create lasting economic opportunity.

“This partnership reflects our commitment to building long-term, sustainable economic opportunities for Mistawasis Nêhiyawak and our broader community,” said Robert Daniels, Chief Executive Officer of Misty Ventures. “By combining our experience and market reach with Aplicata’s proven technology and market expertise, we believe we can create a defence sector business that delivers real value for Canada while creating meaningful opportunities for our people.”

“Aplicata brings a long history of innovation in advanced technologies for defence,” said Mohammad Darwish, Chief Executive Officer of Aplicata Technologies. “Partnering with Misty Ventures allows us to bring our capabilities to the Canadian defence market in a way that also creates lasting economic benefit for Mistawasis Nêhiyawak. We’re excited about the opportunity to build something meaningful together.”

About Misty Ventures

Since 2015, Misty Ventures has been the economic development entity of Mistawasis Nêhiyawak, growing through strategic partnerships across Saskatchewan’s construction, mining, oil and gas, and renewable energy sectors. Misty Ventures continues to pursue investments and collaborations aligned with its vision, mission, and values.

www.mistyventures.ca

About Aplicata Technologies

Aplicata is a trusted leader in high-performance computing platforms for mission-critical defence applications. We create innovative solutions engineered for performance and reliability, delivering results our customers can depend on. Rooted in a culture of collaboration and driven by a shared sense of purpose, we serve government and commercial organizations alike, pushing the boundaries of technology to enable new possibilities.

www.aplicata.com

Media Contact

Media Relations, Aplicata Technologies, 1 (844) 250-6300, media@aplicata.com, www.aplicata.com

View original content to download multimedia:https://www.prweb.com/releases/misty-ventures-and-aplicata-technologies-announce-strategic-partnership-to-pursue-canadian-defence-opportunities-302917752.html

SOURCE Aplicata Technologies

Continue Reading

Trending